Impact of serum levels and gene polymorphism of cytokines on chronic hepatitis C infection

Translational Research

Volumn 150, Issue 2, 2007, Pages 116-121

  Chen, Tzy Yen ^a,b   Hsieh, Yih Shou ^a   Wu, Triang Tiau ^a   Yang, Shun Fa ^a   Wu, Chia Jun ^a   Tsay, Gregory J ^a,b   Chiou, Hui Ling ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; BLOOD LEVEL; CLEARANCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS C; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 34447517238     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2007.01.007     Document Type: Article

References (34)

1. Van der Poel C.L., Cuypers H.T., Reesink H.W., Weiner A.J., Quan S., Di Nello R., et al. Confirmation of hepatitis C virus infection by second generation four-antigen recombinant immunoblot assay and polymerase chain reaction. Lancet 337 (1991) 317-319
2. Seeff L.B. Natural history of hepatitis C. Hepatology 26 (1997) 21S-28S
3. Boyer N., and Marcellin P. Pathogenesis, diagnosis and management of hepatitis C. J Hepatol 32 (2000) 98-112
4. Barrett S., Goh J., Coughlan B., Ryan E., Stewart S., Cockram A., et al. The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection. Gut 49 (2001) 423-430
5. Zucker S.D. Whomsoever ignores the natural history of the hepatitis C virus is doomed to treat it. Gastroenterology 122 (2002) 578-579
6. Hohler T., Kruger A., Gerken G., Schneider P.M., Meyer zum Buschenfelde K.H., and Rittner C. Tumor necrosis factor alpha promoter polymorphism at position-238 is associated with chronic active hepatitis C. J Med Virol 54 (1998) 173-177
7. Barrett S., Ryan E., and Crowe J. Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin. J Hepatol 30 (1999) 979-983
8. Powell E.E., Edwards-Smith C.J., Hay J.L., Clouston A.D., Crawford D.H., Shorthouse C., et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 31 (2000) 828-833
9. Tsutsumi T., Suzuki T., Shimoike T., Suzuki R., Moriya K., Shintani Y., et al. Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity. Hepatology 35 (2002) 937-946
10. Quiroga J.A., Martin J., Pardo M., and Carreno V. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha. Dig Dis Sci 39 (1994) 2485-2496
11. Cacciarelli T.V., Martinez O.M., Gish R.G., Villanueva J.C., and Krams S.M. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alpha. Hepatology 24 (1996) 6-9
12. Mosmann T.R., and Coffman R.L. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 46 (1989) 111-147
13. Ferrari C., Valli A., Galati L., Penna A., Scaccaglia P., Giuberti T., et al. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 19 (1994) 286-295
14. Lasarte J.J., Garcia-Granero M., Lopez A., Casares N., Garcia N., Civeira M.P., et al. Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C. Hepatology 28 (1998) 815-822
15. Sher A., Gazzinelli R.T., Oswald I.P., Clerici M., Kullberg M., Pearce E.J., et al. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev 127 (1992) 183-204
16. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., and Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24 (1997) 1-8
17. Wilson A.G., Symons J.A., McDowell T.L., McDevit H.O., and Duff G.W. Effects of a polymorphism in the human tumor necrosis factor-a promoter on transcriptional activation. Proc Natl Acad Sci U S A 94 (1997) 3195-3199
18. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102 (1998) 1369-1376
19. Pravica V., Asderakis A., Perrey C., Hajeer A., Sinnott P.J., and Hutchinson I.V. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 26 (1999) 1-3
20. Mulcahy B., Waldron-Lynch F., and McDermott M.F. Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet 59 (1996) 676-683
21. Turner D., Grant S.C., Yonan N., Sheldon S., Dyer P.A., Sinnott P.J., et al. Cytokine gene polymorphisms and heart transplant rejection. Transplantation 64 (1997) 776-779
22. Awad M.R., El Gamel A., Hasleton P., Turner D.M., Sinnott P.J., and Hutchinson I.V. Genotype variation in the transforming growth factor-1 gene: association with transforming growth factor-1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66 (1998) 1014-1020
23. Awad M., Pravica V., and Perrey C. CA repeat allele polymorphism in the first intron of the human interferon-gamma gene is associated with lung allograft fibrosis. Hum Immunol 60 (1999) 43-346
24. Hohler T., Kruger A., and Gerken G. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 111 (1998) 579-582
25. Vickers M.A., Green F.R., Terry C., Mayosi B.M., Julier C., Lathrop M., et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 53 (2002) 1029-1034
26. Yee L.J., Tang J., Herrera J., Kaslow R.A., and Van Leeuwen D.J. Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection. Genes Immun 1 (2000) 386-390
27. Yee L.J., Tang J., Gibson A.W., Kimberly R., Van Leeuwen D.J., and Kaslow R.A. Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology 33 (2001) 708-712
28. Tambur A.R., Ortegel J.W., Ben-Ari Z., Shabtai E., Klein T., Michowiz R., et al. Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipients. Transplantation 71 (2001) 1475-1480
29. Rosen H.R., McHutchison J.G., Conrad A.J., Lentz J.J., Marousek G., Rose S.L., et al. Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C. Am J Gastroenterol 3 (2002) 714-720
30. Vidigal P.G., Germer J.J., and Zein N.N. Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin. J Hepatol 36 (2002) 271-277
31. Dai C.Y., Chuang W.L., Chang W.Y., Chen S.C., Lee L.P., Hsieh M.Y., et al. Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection. J Infect Dis 193 (2006) 98-101
32. Kusumoto K., Uto H., Hayashi K., Takahama Y., Nakao H., Suruki R., et al. Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan. Cytokine 34 (2006) 24-31
33. Park Y.S., Lee K.O., Oh M.J., and Chai Y.G. Distribution of genotypes in the 5′ untranslated region of hepatitis C virus in Korea. J Med Microbiol 47 (1998) 643-647
34. Zhang Y., Li J., Zhan Y., Wu L., Yu X., Zhang W., et al. Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect Immun 72 (2004) 4410-4415